Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

Cancers Originate from Somatic Mutations in a Single Cell

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...

Induced Pluripotent Stem Cells

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...

The Retinoblastoma Gene

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

Karyotyping

Karyotyping

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Alpha-thalassaemia early eluting peak for alpha-thalassaemia --<sup>SEA</sup> carrier screening: a multicentre diagnostic comparison with immunochromatographic strip test and haemoglobin H inclusion test.

Annals of hematology·2026

Same author

C-terminal binding protein 2 is a novel tumor suppressor targeting the MYC-IRF4 axis in multiple myeloma.

Blood advances·2024

Same author

Piperacillin/tazobactam Induced Myelosuppression.

Journal of clinical medicine research·2012

Same author

Quiz page March 2008: fever, anorexia, and renal failure. TINU syndrome.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2008

Search research articles

Related Experiment Video

Updated: Mar 11, 2026

Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma

Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma

Published on: April 15, 2022

Recurrent Cytogenetic Abnormalities in Multiple Myeloma.

Nelson Chun Ngai Chan¹, Natalie Pui Ha Chan²

¹Department of Anatomical and Cellular Pathology, Prince of Wales Hospital, 30-32 Ngan Shing Street, Shatin, Hong Kong. nelsonchan@cuhk.edu.hk.

Methods in Molecular Biology (Clifton, N.J.)

|December 3, 2016

Summary

Chromosomal abnormalities in multiple myeloma are key to understanding disease progression and tailoring treatments. This study reviews methods for detecting these changes and their role in risk stratification.

Keywords:

Conventional cytogenetics Hyperdiploid IGH translocation Interphase FISH Myeloma Risk stratification

More Related Videos

Chromosome Preparation From Cultured Cells

Chromosome Preparation From Cultured Cells

Published on: January 28, 2014

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis

Published on: May 1, 2015

Related Experiment Videos

Last Updated: Mar 11, 2026

Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma

Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma

Published on: April 15, 2022

Chromosome Preparation From Cultured Cells

Chromosome Preparation From Cultured Cells

Published on: January 28, 2014

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis

Published on: May 1, 2015

Area of Science:

Hematology
Oncology
Cytogenetics

Background:

Multiple myeloma is a complex blood cancer characterized by significant biological heterogeneity.
Understanding genetic alterations is crucial for predicting patient outcomes and guiding treatment strategies.

Purpose of the Study:

To review techniques used to identify chromosomal abnormalities in multiple myeloma.
To discuss the prognostic significance of recurrent chromosomal aberrations.
To outline updated risk stratification systems based on genetic findings.

Main Methods:

Review of established cytogenetic and molecular techniques (e.g., FISH, SKY, G-banding, SNP arrays, next-generation sequencing).
Analysis of literature on the clinical impact of specific chromosomal abnormalities.
Examination of current risk stratification models incorporating genetic data.

Main Results:

Identification of common and recurrent chromosomal abnormalities in multiple myeloma.
Correlation between specific genetic alterations and patient prognosis (e.g., survival rates, treatment response).
Integration of cytogenetic data into refined risk stratification systems.

Conclusions:

Chromosomal abnormalities are critical determinants of multiple myeloma behavior.
Accurate detection and interpretation of these aberrations are essential for personalized medicine.
Updated risk stratification improves prognostic accuracy and therapeutic decision-making in multiple myeloma.